Clinical Trial Update: A Study of MabThera (Rituximab) Plus Chlorambucil in Patients With Previously Untreated Chronic Lymphocytic Leukemia. [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating MabThera (rituximab) plus chlorambucil in patients with previously untreated chronic lymphocytic leukemia; the study has completed and …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia

Drugs mentioned

• Chlorambucil (chlorambucil)
• MabThera (rituximab)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Lymphocytic Leukemia, Chronic | Phase 2 | Status: COMPLETED | Results posted: 2015-02-16